GenSight Biologics
SIGHT.PA
$0.19
Share price
6.94%
Change (1 day)
-44.29%
Change (1 year)
GenSight Biologics (SIGHT.PA) - Cash on Hand
Cash on Hand as of December 2024 : $2.56 Million USD
According to GenSight Biologics's latest financial reports the company has $2.56 Million USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
GenSight Biologics - Cash on Hand chart (from 2014 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $2.35 M | -79.27% |
| 2022-12-31 | $11.38 M | -77.31% |
| 2021-12-31 | $50.15 M | 7.47% |
| 2020-12-31 | $46.66 M | 116.42% |
| 2019-12-31 | $21.56 M | -28.17% |
| 2018-12-31 | $30.01 M | -54.88% |
| 2017-12-31 | $66.52 M | 17.17% |
| 2016-12-31 | $56.78 M | 72.76% |
| 2015-12-31 | $32.86 M | 123.87% |
| 2014-12-31 | $14.68 M | -37.81% |
| 2013-12-31 | $23.6 M | 94593.57% |
| 2012-12-31 | $0.02 M |